Danish plans for national guidance on API audits criticised
This article was originally published in SRA
Executive Summary
Plans by the Danish Medicines Agency to develop national guidelines that would assist drug companies in auditing sites manufacturing active pharmaceutical ingredients have come in for criticism from some quarters1.